Table II.

Effect of rapamycin and doxorubicin on apoptosis in K562 cells.

		Apoptosis (%)
Group	Early	Later	Total
Control	5.63±0.61	2.83±0.50	8.47±0.95
Doxo	9.13±0.90a	5.73±0.65a	14.87±1.34a
Rapa	8.30±0.66a	3.93±0.87	12.23±1.37a
Doxo+Rapa	18.10±1.37a,b	7.40±0.62a,b	25.50±1.25a,b

^aP<0.05 vs. the solvent control group

^bP<0.05 vs. the single drug treatment. Doxo, doxorubicin; Rapa, rapamycin.